{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:16Z","timestamp":1794248596646,"version":"4.9.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,21]]},"abstract":"<jats:p>\n                    The significance of adropin levels in chronic renal failure patients has not yet been established. This study\u2019s objectives were to compare serum adropin levels in hemodialysis patients with chronic renal failure and healthy patients as well as the clinical parameters corresponding with the levels. The total sample comprised of 49 hemodialysis individuals and 36 controls. We measured serum adropin concentrations using enzyme-linked immunosorbent assay method and analyzed various biochemical parameters including creatinine, uric acid, C-reactive protein, albumin, parathyroid hormone, and hemoglobin levels. In the patients there were statistically significant lower levels of serum adropin determined at 522.7\u2005\u00b1\u2005169.4 versus 789.6\u2005\u00b1\u2005259.3\u2005ng\/L,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01. Strong negative correlations were observed between adropin levels and both creatinine (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u2005\u22120.613,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and parathyroid hormone (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u2005\u22120.621,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Additionally, moderate positive correlations were found with albumin (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u20050.534,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and hemoglobin (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u20050.445,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). There were also statistically significant differences in hemoglobin A1c of the patients and control populations with levels of 5.7\u2005\u00b1\u20051.8 versus 5.2\u2005\u00b1\u20050.5,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.04 and C-reactive protein levels of 21.8\u2005\u00b1\u200528.9 versus 1.4\u2005\u00b1\u20052.6\u2005mg\/L,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01 respectively. These findings suggest that reduced adropin levels in hemodialysis patients are significantly associated with markers of renal dysfunction, inflammation, and nutritional status, indicating its potential role in the pathophysiology of chronic renal failure.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041860","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:33:11Z","timestamp":1743035591000},"page":"e41860","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Measurement of serum adropin levels in chronic renal failure patients receiving routine hemodialysis treatment"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2209-5437","authenticated-orcid":false,"given":"Adil Furkan","family":"Kili\u00e7","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Health Sciences University, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7821-8275","authenticated-orcid":false,"given":"Edip","family":"Erku\u015f","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Health Sciences University, Erzurum, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-3880","authenticated-orcid":false,"given":"Lale","family":"Duysak","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Biochemistry, Ataturk University, Faculty of Pharmacy, Erzurum, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261109","first-page":"337","article-title":"Serum adropin levels in patients on hemodialysis.","volume":"11","author":"Boric-Skaro","year":"2021","journal-title":"Life (Basel)"},{"key":"R2-20261109","first-page":"88","article-title":"Serum adropin levels in relation to nutritional status in hemodialysis patients.","volume":"5","author":"Esmael","year":"2023","journal-title":"Al-Azhar Univ J Virus Res Stud"},{"key":"R3-20261109","first-page":"474","article-title":"Adropin and irisin levels in relation to nutrition, body composition, and insulin resistance in patients with end-stage renal disease on chronic hemodialysis and peritoneal dialysis.","volume":"126","author":"Ka\u0142u\u017cna","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"R4-20261109","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/met.2021.0015","article-title":"Correlation of serum adropin levels with risk factors of cardiovascular disease in hemodialysis patients.","volume":"19","author":"Liu","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"key":"R5-20261109","first-page":"39","article-title":"Adropin and irisin in patients with cardiac cachexia.","volume":"111","author":"Kalkan","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"R6-20261109","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.17219\/acem\/104551","article-title":"Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease.","volume":"28","author":"Maciorkowska","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/biomedicines11020457","article-title":"The impact of SGLT2 inhibitor dapagliflozin on adropin serum levels in men and women with type 2 diabetes mellitus and chronic heart failure.","volume":"11","author":"Berezin","year":"2023","journal-title":"Biomedicines"},{"key":"R8-20261109","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1159\/000519173","article-title":"The clinical value of serum adropin level in early detection of diabetic nephropathy.","volume":"46","author":"Es-haghi","year":"2021","journal-title":"Kidney Blood Press Res"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"347","DOI":"10.17219\/acem\/81538","article-title":"Adropin and irisin: new biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study.","volume":"28","author":"Ka\u0142u\u017cna","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3390\/diagnostics13193158","article-title":"Clinical significance of adropin and afamin in evaluating renal function and cardiovascular health in the presence of CKD-MBD biomarkers in chronic kidney disease.","volume":"13","author":"Kaur","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/jcm12062231","article-title":"Adropin predicts chronic kidney disease in type 2 diabetes mellitus patients with chronic heart failure.","volume":"12","author":"Berezina","year":"2023","journal-title":"J Clin Med"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1177\/15353702211012417","article-title":"Inflammatory response and matrix metalloproteinases in chronic kidney failure: modulation by adropin and spexin.","volume":"246","author":"Yazgan","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s11255-020-02568-x","article-title":"Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.","volume":"52","author":"Li","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"R14-20261109","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","article-title":"Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.","volume":"76","author":"Li","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"R15-20261109","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription.","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat Commun"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000500106","article-title":"Serum adropin levels are reduced in adult patients with nonalcoholic fatty liver disease.","volume":"28","author":"Kutlu","year":"2019","journal-title":"Med Princ Pract"},{"key":"R17-20261109","first-page":"2194","article-title":"Study of the relationship between serum adropin level and nutritional status in hemodialysis patients.","volume":"5","author":"Kamel","year":"2023","journal-title":"Zagazig Univ Med J"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"6038261","DOI":"10.1155\/2016\/6038261","article-title":"Association of serum adropin concentrations with diabetic nephropathy.","volume":"2016","author":"Hu","year":"2016","journal-title":"Mediators Inflamm"},{"key":"R19-20261109","first-page":"402","article-title":"Assessment of the relationship between the adropin levels and the coronary collateral circulation in patients with chronic coronary syndrome [Avalia\u00e7\u00e3o da Rela\u00e7\u00e3o entre N\u00edveis de Adropina e Circula\u00e7\u00e3o Colateral Coron\u00e1ria em Pacientes com S\u00edndrome Coronariana Cr\u00f4nica].","volume":"119","author":"Akkaya","year":"2022","journal-title":"Arq Bras Cardiol"},{"key":"R20-20261109","first-page":"1","article-title":"Association of serum adropin levels with nutritional status and lipid profile in patients with kidney failure with replacement therapy.","volume":"30","author":"Depboylu","year":"2023","journal-title":"Galician Med J"},{"key":"R21-20261109","doi-asserted-by":"crossref","first-page":"9264","DOI":"10.1038\/s41598-020-66254-9","article-title":"Serum adropin levels are reduced in patients with inflammatory bowel diseases.","volume":"10","author":"Brni\u0107","year":"2020","journal-title":"Sci Rep"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/ijmm.2024.5414","article-title":"Unveiling the multifaceted role of adropin in various diseases.","volume":"54","author":"Chen","year":"2024","journal-title":"Int J Mol Med"},{"key":"R23-20261109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20420188241252309","article-title":"Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor.","volume":"15","author":"Lin","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"100299","DOI":"10.1016\/j.metop.2024.100299","article-title":"Adropin: a crucial regulator of cardiovascular health and metabolic balance.","volume":"23","author":"Rooban","year":"2024","journal-title":"Metabol Open"},{"key":"R25-20261109","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3390\/jcm12062231","article-title":"Adropin predicts chronic kidney disease in type 2 diabetes mellitus patients with chronic heart failure.","volume":"12","author":"Berezina","year":"2023","journal-title":"J Clin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:00:50Z","timestamp":1794247250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041860","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}